C. Gottfries

发表

Antibodies in cerebrospinal fluid of some Alzheimer disease patients recognize cholinergic neurons in the rat central nervous system.

A. Dahlström, K. Haglid, A. Wallin, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age.

K. Blennow, A. Wallin, I. Skoog, 1993, European neurology.

The role of amyloid β-protein in Alzheimer's disease

B. Regland, C. Gottfries, 1992, The Lancet.

Antibodies in the CSF of a Parkinson patient recognizes neurons in rat mesencephalic regions.

A. Dahlström, C. Gottfries, I. Karlsson, 1986, Acta physiologica Scandinavica.

Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia

K. Blennow, A. Wallin, P. Davidsson, 1992, Acta neurologica Scandinavica.

Low blood pressure and blood glucose levels in Alzheimer's disease Evidence for a hypometabolic disorder?

K. Blennow, A. Wallin, K. Landin, 1993, Journal of internal medicine.

Delirium in dementia

K. Blennow, A. Wallin, C. Gottfries, 1998, International journal of geriatric psychiatry.

Ubiquitin in Cerebrospinal Fluid in Alzheimer's Disease and Vascular Dementia

K. Blennow, A. Wallin, P. Davidsson, 1994, International Psychogeriatrics.

The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type.

M. Jonsson, M. Sjögren, A. Wallin, 2001, Acta ophthalmologica Scandinavica.

Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue

K. Blomgren, K. Blennow, I. Alafuzoff, 1990, Neurobiology of Aging.

5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders

B. Winblad, I. Alafuzoff, J. Marcusson, 1987, Brain Research.

Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'.

K. Blennow, A. Wallin, P. Davidsson, 1991, Archives of neurology.

Investigations on auto-antibodies in Alzheimer's and Parkinson's diseases, using defined neuronal cultures.

A. Dahlström, P. Carvey, C. Gottfries, 1990, Journal of neural transmission. Supplementum.

HOMOVANILLIC ACID AND 5‐HYDROXYINDOLEACETIC ACID IN THE CEREBROSPINAL FLUID OF PATIENTS WITH SENILE DEMENTIA, PRESENILE DEMENTIA AND PARKINSONISM

B. Roos, C. Gottfries, I. Gottfries, 1969, Journal of neurochemistry.

Differences in cerebrospinal fluid gangliosides between “probable Alzheimer’s disease” and normal aging

K. Blennow, A. Wallin, P. Davidsson, 1992, Aging.

Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio.

K. Blennow, A. Wallin, G. Långström, 1993, European neurology.

Intrathecal synthesis of immunoglobulin G in vascular dementia

K. Blennow, A. Wallin, I. Karlsson, 1990, Acta neurologica Scandinavica.

Studies on duration of a late recovery period after chronic abuse of ethanol

C. Alling, G. Långström, J. Balldin, 1982, Acta psychiatrica Scandinavica.

Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid

K. Blennow, A. Wallin, J. Månsson, 1993, Journal of neural transmission. Parkinson's disease and dementia section.

Confusional symptomatology distinguishes early— and late- onset Alzheimer’s disease

K. Blennow, A. Wallin, C. Gottfries, 1990, Aging.

Antibodies in the cerebrospinal fluid of some Alzheimer's disease patients recognize amoeboid microglial cells in the developing rat central nervous system

A. Dahlström, E. Ling, R. Polinsky, 1991, Neuroscience.

The presence of antibrain antibodies in the CSF of some Alzheimer disease patients: correlation with CSF parameters

K. Blennow, A. Dahlström, A. Wallin, 1990 .

CSF of Patients with Alzheimer’s Disease Contain Antibodies Recognizing Cholinergic Cells in the Rat CNS, and can Protect Cholinergic Neuronal Cultures

K. Blennow, A. Dahlström, C. Gottfries, 1990 .

Quantitative changes in the amyloid βA4 precursor protein in Alzheimer cerebrospinal fluid

C. Masters, U. Schreiter-Gasser, K. Beyreuther, 1991, Neuroscience Letters.

Diverse characteristics of the urinary excretion of amino acids in humans and the use of amino acid supplementation to reduce fatigue and sub-health in adults

B. Dascombe, J. Gottfries, T. Roberts, 2017, Nutrition Journal.

STUDIES OF THE MONOAMINE METABOLISM IN THE CENTRAL NERVOUS SYSTEM IN JAKOB‐CREUTZFELDT DISEASE

A. Brun, B. Roos, C. Gottfries, 1971, Acta neurologica Scandinavica.

Parenteral administration of GM1 ganglioside to presenile Alzheimer patients

K. Blennow, A. Wallin, J. Månsson, 1990, Acta neurologica Scandinavica.

Sex differences in amino acids lost via sweating could lead to differential susceptibilities to disturbances in nitrogen balance and collagen turnover

B. Dascombe, J. Gottfries, C. Stevens, 2017, Amino Acids.

Monoamines and monoamine metabolites in brains from demented schizophrenics

B. Winblad, G. Bucht, C. Gottfries, 1979, Acta psychiatrica Scandinavica.

Lack of Efficacy of Vinpocetine in Vascular Dementia

K. Blennow, A. Wallin, A. Nyth, 1990 .

Neurochemical aspects on aging and diseases with cognitive impairment

C. Gottfries, 1990, Journal of neuroscience research.

Vitamin B12 in CSF: reduced CSF/serum B12 ratio in demented men

K. Blennow, A. Wallin, B. Regland, 1992, Acta neurologica Scandinavica.

Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18–88 years of age

K. Blennow, A. Wallin, I. Skoog, 1993, European Neuropsychopharmacology.

A double‐blind evaluation of electroconvulsive therapy in Parkinson's disease with “on‐off” phenomena

A. Wallin, J. Balldin, L. Svennerholm, 1987, Acta neurologica Scandinavica.

Immunocytochemical investigations on the presence of neuron-specific antibodies in the CSF of Parkinson's disease cases

A. Dahlström, K. Haglid, L. Rosengren, 1988, Neurochemical Research.

Hyperactivity in the hypothalamic-pituitary-adrenal axis in demented patients with delirium

K. Blennow, Å. Edman, A. Wallin, 2001, International clinical psychopharmacology.

Low B12 levels related to high activity of platelet MAO in patients with dementia disorders

L. Oreland, B. Regland, L. Svennerholm, 1988, Acta psychiatrica Scandinavica.

Neurotransmitter deficits in a non‐multi‐infarct category of vascular dementia

B. Winblad, I. Alafuzoff, A. Carlsson, 1989, Acta neurologica Scandinavica.

Biological markers in dementia

C. Gottfries, C. Gottfries, 1988 .

Blood‐brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors

I Karlsson, K. Blennow, A. Wallin, 1990, Acta neurologica Scandinavica.

A population study on blood-brain barrier function in 85-year-olds

K. Blennow, A. Wallin, I. Skoog, 1998, Neurology.

Biochemical substrates in normal aging and Alzheimer's disease.

A. Wallin, C. Gottfries, 1990, Pharmacopsychiatry.

Monoamine Metabolites in Cerebrospinal Fluid and Behavioral Ratings in Patients with Early and Late Onset of Alzheimer Dementia

K. Blennow, L. Parnetti, A. Wallin, 1989, Alzheimer disease and associated disorders.

White‐matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors

K. Blennow, A. Wallin, C. Gottfries, 1991, Acta neurologica Scandinavica.

Dexamethasone Suppression Test and Serum Prolactin in Dementia Disorders

G. Långström, J. Balldin, I. Karlsson, 1983, British Journal of Psychiatry.

Diagnosis of dementias using partial least squares discriminant analysis.

J Gottfries, K. Blennow, A. Wallin, 1995, Dementia.

Relationship between mental impairment and HPA axis activity in dementia disorders.

K. Blennow, A. Wallin, G. Bråne, 1994, Dementia.

VISUAL AVERAGED EVOKED RESPONSES (AER) AND MONOAMINE METABOLITES IN CEREBROSPINAL FLUID (CSF)

C. Gottfries, C. Perris, B. Roos, 1974, Acta psychiatrica Scandinavica. Supplementum.

Alaproclate: A pharmacokinetic and biochemical study in patients with dementia of Alzheimer type

G. Bråne, C. Gottfries, I. Karlsson, 2004, Psychopharmacology.

Antibodies recognizing cholinergic neurons and thyroglobuline are found in the cerebrospinal fluid of a subgroup of patients with Alzheimer's disease

K. Blennow, A. Dahlström, K. Haglid, 1988 .

DETERMINATION OF 5‐HYDROXYTRYPTAMINE, 5‐HYDROXYINDOLEACETIC ACID AND HOMOVANILLIC ACID IN BRAIN TISSUE FROM AN AUTOPSY MATERIAL

B E Roos, B. Winblad, B Winblad, 1974, Acta psychiatrica Scandinavica.

White matter low attenuation on computed tomography in Alzheimer's disease and vascular dementia – diagnostic and pathogenetic aspects

K. Blennow, A. Wallin, G. Långström, 1989, Acta neurologica Scandinavica.

Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer's disease.

I. Alafuzoff, A. Carlsson, J. Marcusson, 1990, European neurology.

Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics

R. Ekman, C. Gottfries, E. Widerlöv, 1991, Acta psychiatrica Scandinavica.

Decreased myelin lipids in Alzheimer's disease and vascular dementia

A. Wallin, I. Karlsson, L. Svennerholm, 1989, Acta neurologica Scandinavica.

Blood brain barrier function in vascular dementia

K. Blennow, A. Wallin, C. Gottfries, 1990, Acta neurologica Scandinavica.

Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography‐mass spectrometry

L. Parnetti, J. Gottfries, G. Långström, 1987, Acta psychiatrica Scandinavica.

4. Brain monoamines and their metabolites in dementia

C. Gottfries, 1990 .

Regulation of the Hypothalamic‐Pituitary‐Adrenal Axis in Dementia Disorders

K. Blennow, A. Wallin, G. Bråne, 1994, Annals of the New York Academy of Sciences.

HUNTINGTON'S CHOREA: PATHOLOGY AND BRAIN AMINES

B. Winblad, B. Roos, C. Gottfries, 1974, Acta Psychiatrica Scandinavica Supplementum.

Sex differences in amino acids lost via sweating could lead to differential susceptibilities to disturbances in nitrogen balance and collagen turnover

B. Dascombe, J. Gottfries, C. Stevens, 2017, Amino Acids.

Quantitative determination of the amyloid A4 precursor protein in cerebrospinal fluid

K. Blennow, K. Beyreuther, P. Fischer, 1990, Neurobiology of Aging.